Wuppertal, Germany

Gabriele Braunlich


Average Co-Inventor Count = 7.6

ph-index = 3

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 1996-1999

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gabriele Braunlich: Innovator in Medicinal Chemistry

Introduction

Gabriele Braunlich is a prominent inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target inflammatory processes. With a total of 5 patents to his name, Braunlich's work is recognized for its potential therapeutic applications.

Latest Patents

One of Braunlich's latest patents involves the synthesis of heterocyclylcarbonyl substituted benzofuranyl-ureas. These compounds are prepared by reacting heterocyclylcarbonyl substituted 3-amino-benzofuranes with appropriate isocyanates or isothiocyanates. The unsubstituted ureas can be transformed into substituted ureas through standard substitution methods. These heterocyclylcarbonyl substituted benzofuranyl-ureas are particularly useful as active ingredients in medicaments aimed at treating both acute and chronic inflammatory processes. Another notable patent focuses on heterocyclylcarbonyl substituted benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives. These are synthesized by reacting appropriately substituted hydroxybenzene butanoic acid esters with heterocyclic ketones. The resulting compounds are intended for the preparation of medicaments that prevent and treat inflammatory conditions.

Career Highlights

Gabriele Braunlich is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to explore innovative solutions in drug development, particularly in the realm of inflammatory diseases. Braunlich's expertise in medicinal chemistry has positioned him as a valuable asset in the research and development sector.

Collaborations

Throughout his career, Braunlich has collaborated with notable colleagues, including Rudiger Fischer and Mazen Es-Sayed. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective medicinal compounds.

Conclusion

Gabriele Braunlich's contributions to medicinal chemistry, particularly through his innovative patents, highlight his commitment to advancing healthcare solutions. His work continues to impact the treatment of inflammatory processes, showcasing the importance of research and collaboration in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…